Novo Nordisk A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Novo Nordisk A/S generated cash of $108,908,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$63,158,000,000 last year. Net change in cash is therefore $1,739,000,000.
Cash Flow
| 2014 | 31.69B | -2.06B | -26.53B |
|---|---|---|---|
| 2015 | 38.28B | -6.09B | -30.10B |
| 2016 | 48.31B | -6.79B | -38.88B |
| 2017 | 41.16B | -6.57B | -35.68B |
| 2018 | 44.61B | -12.08B | -34.52B |
| 2019 | 46.78B | -11.50B | -35.48B |
| 2020 | 51.95B | -22.43B | -32.24B |
| 2021 | 55B | -31.60B | -25.49B |
| 2022 | 78.88B | -24.91B | -51.79B |
| 2023 | 108.90B | -43.89B | -63.15B |
NVO Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 12.65B | 10.71B | 12.22B | 15.41B | 15.62B | 17.15B | 18.46B | 15.85B | 13.67B | 10.51B |
Operating activities | ||||||||||
Net income | 83.68B | 55.52B | 47.75B | 42.13B | 38.95B | 38.62B | 38.13B | 37.92B | 34.86B | 26.48B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 9.41B | 7.36B | 6.02B | 5.75B | 5.66B | 3.92B | 3.18B | 3.19B | 2.95B | 3.43B |
Stock-based compensation expense | 2.14B | 1.53B | 1.04B | 823M | 363M | 414M | 292M | 368M | 442M | 371M |
| Deferred income tax benefit | 2.14B | 1.53B | 1.04B | 823M | 363M | 414M | 292M | 368M | 442M | 371M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -14.21B | -9.91B | -12.90B | -2.82B | -2.12B | -2.62B | 69M | -4.74B | -2.44B | -2.13B |
Inventories | -7.42B | -4.76B | -1.08B | -895M | -1.30B | -963M | -1.03B | -1.58B | -1.40B | -1.80B |
Accounts payable | 10.01B | 6.71B | 3.15B | -641M | -398M | 1.14B | -401M | 1.08B | -23M | 858M |
Cash generated by operating activities | 108.90B | 78.88B | 55B | 51.95B | 46.78B | 44.61B | 41.16B | 48.31B | 38.28B | 31.69B |
Investing activities | ||||||||||
Purchases Of Investments | -13.28B | -9.73B | -7.11B | 16.25B | -350M | -248M | -40M | -643M | -3.54B | 0 |
Investments In Property Plant And Equipment | -25.80B | -14.75B | -7.38B | -22.08B | -11.23B | -12.41B | -8.64B | -8.26B | -6.40B | -4.33B |
Acquisitions Net | 0 | -7.07B | -18.28B | -392M | -100M | 368M | 1.02B | 1.19B | 2.30B | 0 |
Cash generated by investing activities | -43.89B | -24.91B | -31.60B | -22.43B | -11.50B | -12.08B | -6.57B | -6.79B | -6.09B | -2.06B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -31.76B | -25.30B | -21.51B | -20.12B | -19.40B | -19.04B | -18.84B | -23.83B | -12.90B | -11.86B |
Repurchases of common stock | -29.92B | -24.08B | -19.44B | -16.85B | -15.33B | -15.56B | -16.84B | -15.05B | -17.19B | -14.66B |
Repayments of term debt | -1.46B | -2.40B | -6.68B | -950M | -741M | -94M | 0 | 0 | 0 | 0 |
Cash used in financing activities | -63.15B | -51.79B | -25.49B | -32.24B | -35.48B | -34.52B | -35.68B | -38.88B | -30.10B | -26.53B |
Net Change In Cash | 1.73B | 1.93B | -1.50B | -3.18B | -218M | -1.52B | -1.30B | 2.61B | 2.17B | 3.16B |
Cash at end of period | 14.39B | 12.65B | 10.71B | 12.22B | 15.41B | 15.62B | 17.15B | 18.46B | 15.85B | 13.67B |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |